NCT01598194View on ClinicalTrials.gov

Comparison of a Novel 22-gauge Core Biopsy Needle

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 30, 2012

Primary Completion Date

July 6, 2017

Study Completion Date

July 6, 2017

Conditions
Solid Pancreatic Mass LesionsMalignant Neoplasm of Pancreas
Interventions
DEVICE

Novel 22-gauge Core Biopsy Needle + Standard Biopsy Needle

Two passes performed with the standard 22-gauge or 25-gauge straight hollow core needle and two passes will be performed using the 22-gauge EchoTip® Procore™ needle. All passes will be taken from a single lesion and from the same endoscopic location.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT01598194 - Comparison of a Novel 22-gauge Core Biopsy Needle | Biotech Hunter | Biotech Hunter